← SynDRA
LATANOPROST
SynDRA canonical compound SYN0003403 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | PTGFR |
| Mechanism of action | prostanoid receptor agonist |
| Indication | glaucoma | ocular hypertension |
| Disease area | ophthalmology |
All known targets
Mechanisms of action (all sources)
- PTGFR AGONIST
- Prostanoid FP receptor agonist
- prostanoid receptor agonist
Drug classes
- Prostaglandin Analog
- Ophthalmic Solutions
- Pharmaceutical Solutions
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Cross-references
Synonyms
- roclanda
- xalatan
- (15R)-Latanoprost
- PhXA41
- Iyuzeh
- Latanoprost (isopropyl ester)
- PHXA-41
- PHXA41
- T-2345
- T2345
- XA-41
- XA41
- Catiolanze
- Latanoprost component of rocklatan
- Latanoprost component of xalacom
- Monopost
- Xalatan
- Xelpros
- Catioprost
- Latanoprost free acid
- L1167_SIGMA
- AR-202
- Nova-21027
- Xalatan (TN)
- Latanoprost (JAN/USAN/INN)
- PhXA34 [as 15(R,S)-isomer]
- Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate
- Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate
- Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
- Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
- Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
- PhXA 41
- XA 41
- latanoprost (isopropyl ester)
- propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
- Latanoprost, (+/-)-
- 6Z5B6HVF6O
- 8S5FB3XXG8
Reported adverse events
- Eyelash changes
- Asthma
- Rash
- Nausea
- Chest pain
- Dizziness
- Dry eye
- Myalgia
- Photophobia
- Eye pain
- Foreign body
- Punctate keratitis
Look up LATANOPROST in the interactive SynDRA portal →